Growing evidences suggest that the multifunctional protein E4F1 is involved in signalling pathways that play essential roles during normal development and tumorigenesis. Here, we have generated E4F1 conditional knock-out mice to address E4F1 functions in vivo in newborn and adult skin. E4F1 inactivation in the entire skin or in the basal compartment of the epidermis induces skin homeostasis defects, as evidenced by transient hyperplasia in the interfollicular epithelium and alteration of keratinocyte differentiation, followed by loss of cellularity in the epidermis and severe skin ulcerations. E4F1 depletion alters Epidermal Stem Cells (ESC) clonogenic activity ex vivo and ends in exhaustion of the ESC pool in vivo, indicating that the lesions observed in the E4F1 mutant skin result, at least partly, from cell autonomous alterations in ESC maintenance. Clonogenic potential of E4F1 KO ESC is rescued by Bmi1 over-expression or by Ink4a/Arf or p53 depletion. Skin phenotype of E4F1 KO mice is also delayed in animals with Ink4a/Arf and E4F1 compound gene deficiencies. Our data identify a novel regulatory axis essential for ESC-dependent skin homeostasis implicating E4F1 and the Bmi1-Arf-p53 pathway. Abbreviations: ESC, Epidermal Stem Cells; HF, Hair Follicle; 4OHT, 4-Hydroxy Tamoxifen; IFE, Interfollicular Epithelium; K5, K6, K10, K14 and K15, Keratin-5, 6, 10, 14 and 15 respectively; KO, Knock-Out; LRC, Label Retaining Cells; RERT , Cre-ER T2 knock-in mice; TAC, Transit Amplifying Compartment.
/body Introduction:
E4F1 is an ubiquitously expressed transcription factor of the Gli-Kruppel family that was identified as a cellular target of the adenoviral oncoprotein E1A (1). While several cellular targets of E1A (E2F/pRB, CBP/p300, PCAF, CtBP, ATF/Creb etc…) have been extensively studied and recognized as central regulators of cell proliferation and survival, E4F1 biological functions remained poorly investigated. E4F1 is a multifunctional protein with transcriptional and atypical ubiquitin E3-ligase activities. E4F1-mediated ubiquitylation of p53 does not lead to proteasomal degradation but modulates p53 transcriptional activities involved in alternative cell fates: growth arrest or apoptosis (2) . The notion that E4F1 plays an important role in the p53 pathway is reinforced by other reports showing that E4F1 not only directly interacts with p53 itself (2, 3) but also with regulators/effectors of this pathway, including p14 ARF (4), the polycomb member Bmi1 (5) , and the p53 target gene FHL2 (6) .
Nevertheless, E4F1 functions most likely extend beyond the regulation of p53. Thus, physical interactions between E4F1 and components of other oncogenic pathways have been reported, including RASSF1A (7) , pRB (8) , HMGA2 (9) and Smad4 (10) .
Using a gene targeting approach in mouse, we previously showed that E4F1 constitutive inactivation results in embryonic lethality around the time of implantation. E4F1 KO blastocysts in culture exhibit mitotic defects including lagging chromosomes, chronic activation of the mitotic checkpoint, and massive cell death (11) . More recently, shRNAmediated partial depletion of E4F1 was also shown to rescue hematopoietic stem cell (HSC) exhaustion in mouse resulting from inactivation of the polycomb member Bmi1 (5), suggesting an important role for E4F1 in HSC homeostasis.
To date, little information is currently available regarding the in vivo functions of E4F1 in adult tissues. Here, we generated several mouse strains to explore the roles of E4F1 in skin homeostasis. 4 Constant renewal of the Interfollicular Epithelium (IFE) and of Hair Follicles (HF) relies on the recruitment of epidermal stem cells (ESC) located in the basal layer of the IFE and in the bulge region of HF, respectively. ESC fuel the highly proliferative transit amplifying compartments (TAC) in the basal layer of the IFE and in the bulb of the HF. TAC cells then embark on differentiation programs to generate the spinous, granular and cornified layers in the IFE or the different lineages of the mature HF (12) (13) (14) . Several essential molecular circuitries that orchestrate epidermal stem cells maintenance have been previously described, including p63-, BMP-, TGF-ß-, Wnt/ß-catenin-, and Notch-initiated signalling cascades (12, 15, 16) .
Here, we show that inactivation of E4F1 in the entire skin or in the basal compartment of the epidermis results in severe epidermal defects both in neonates and in adult mice, revealing a yet unidentified regulatory axis essential for ESC-dependent skin homeostasis implicating E4F1 and the Bmi1-Ink4a/Arf-p53 pathway.
Results:
Inactivation of E4F1 induces transient hyperplasia in the epidermis followed by permanent loss of epidermal cells and severe skin ulcerations.
We first investigated E4F1 expression pattern in epidermis. Immunohistochemical analyses of murine and human skin sections showed nuclear expression of E4F1 in the basal and suprabasal layers of the interfollicular epithelium (IFE), as well as in the bulb and bulge regions of the hair follicle (HF) (Fig. 1A) .
To analyse the role of E4F1 in skin homeostasis, we generated two mouse models with homozygote deletion of the E4F1 gene in the entire skin or in the epidermis only, using conditional (Cre-ER T2 ) and tissue specific (K5-Cre) Cre/Lox-P systems, respectively. In short, we first generated E4F1 -/flox mice harboring E4F1 conditional knock-out allele ( Fig. S1 ) and
inter-crossed them with Cre-ER T2 KI/KI mice (RERT) which express tamoxifen-inducible Cre recombinase-ER T2 fusion protein under the control of the ubiquitously active RNA polII promoter, i.e. in all tissues (17) . As expected, topical applications of 4-hydroxy-tamoxifen (4OHT) on the tail skin or on a shaved area of the back skin of adult E4F1 -/flox ; RERT animals, resulted in efficient Cre-mediated recombination of the E4F1 locus in the skin, as monitored on genomic DNA, mRNA and protein samples prepared from the treated area ( Fig. S1 ).
Between 1 and 2 weeks after 4OHT-administration, E4F1-depleted back skin thickened, became wrinkled and ruffled. Those early lesions evolved 1 to 2 weeks later into severe skin ulcerative lesions ( Fig. 1B) . Strikingly, E4F1 inactivation in unshaved skin tail of E4F1 -/flox ; RERT animals resulted in complete alopecia 6 weeks after 4OHT applications (Fig.   1C ). Histological analyses revealed that skin thickening was the result of a massive hyperplasia of the epidermis with increased cellularity in the IFE and the infundibulum ( were proliferating in E4F1 KO skin, as indicated by increased immunostaining of skin sections for the proliferation marker Ki67 (Fig. 1D ), and anti-BrdU staining performed on skin sections harvested shortly after injection of animals with BrdU ( Fig. S2 ). This phenotype was skin autonomous since similar hyperplasia was recapitulated upon engraftment of E4F1 -/flox ; RERT p1 neonatal back skin onto nude mice ( Fig. S3 ). At later time points (3 to 4 weeks after 4OHT administration), the initial hyperplasia of E4F1 KO; RERT skin was followed by broad disorganisation of the IFE and massive hyperkeratosis associated with partial or complete loss of cellularity in the IFE (Fig. 1D ).
To further show that the observed phenotypes resulted from epidermis specific defects, we crossed E4F1 -/flox mice with Keratin 5-Cre (K5-Cre) transgenic mice expressing Cre in the epidermal basal cell layer, from E15.5 onwards (18) . E4F1 -/flox ; K5-Cre neonates exhibited efficient E4F1 gene inactivation in the epidermis as shown by immunohistochemical staining and western-blot analyses with anti-E4F1 antibodies ( Fig. 1E and S1). 3 to 4 days after birth, these animals exhibited epidermal hyperplasia, and died with acute symptoms of dehydration ( Fig. 1F ). As in E4F -/flox ; RERT animals, this hyperplasia was associated with hyperproliferation of epidermal cells, as shown by increased Ki67 staining ( Fig. 1G ). Consistent with increased proliferation, E4F1 KO epidermis also exhibited higher mitotic index, as illustrated by increased number of phospho histone H3 (Ser10, PHH3) positive basal cells ( Fig. S5 ). Of note, we previously showed that E4F1 KO blastocysts also exhibited PHH3-positive cells (11) , but in this case, cells were blocked in mitosis with abnormal mitotic figures. We did not observe abnormal mitotic figures in E4F1 KO epidermal basal cells, indicating that the increased mitotic index likely reflects over-proliferation of basal cells, rather than mitotic progression defects.
In order to bypass neonatal lethality of E4F1 KO; K5-Cre animals and investigate later phenotypes, we engrafted E4F -/flox ; K5-Cre or control skins onto nude mice. 2 weeks after engraftment, E4F1 KO; K5-Cre skins failed to regenerate a normal epidermis. Similarly to the late phenotype of E4F -/flox ; RERT animals, E4F1 KO, K5-Cre engrafted skins exhibited marked hypocellularity in the epidermis, hyperkeratosis and severe ulcerative lesions ( Fig.   1H ). Of note, hair follicles were also lacking in E4F1 KO, K5-Cre engrafted skins.
Collectively, our data indicate that E4F1 inactivation results in transient hyperplasia but ultimately leads to permanent loss of epidermal cells in the IFE and HFs.
E4F1 inactivation results in expansion of the basal cells compartment of the epidermis and in abnormal keratinocyte differentiation in vivo.
We next assessed which epidermal cell populations were present in these hyperplasic lesions. In both 4OHT-treated E4F1 -/flox ; RERT and E4F1 -/flox ; K5-Cre epidermis, cells of the hyperplasic IFE stained positive for the basal cell-specific keratin-14, integrin-α6, markers ( Fig. 2A and S4 ). Expression of these markers extended to upper cellular layers, in contrast to normal IFE of control animals where their expression was restricted to the basal cell layer. In addition, E4F1-floxed IFE massively expressed keratin-6 ( Fig. 2B and S4 ), which expression is normally restricted to sweat glands and HF in normal skin but can be expressed in the IFE undergoing abnormal proliferation or wound healing (19) . Collectively, these analyses indicated that E4F1 inactivation in the IFE first resulted in massive expansion of keratinocytes with basal/TAC properties.
In addition to this massive expansion of basal cells, we noticed the absence of the suprabasal and granular layers as illustrated by the lack of expression of early (keratins 1 and 10), as well as late differentiation markers (involucrin, loricrin, filaggrin) in E4F1 KO epidermis in both E4F1 flox ; K5-Cre and E4F1 flox ; RERT models ( Fig. 2B, S4 ). No significant cell death was observed among highly proliferative cells of the IFE during the development of hyperplasia, as revealed by immunostaining of skin sections for the presence of activated caspase 3-or TUNEL-positive cells. Therefore, it is likely that hyperproliferative keratinocytes present in hyperplasic lesions had finally undergone an abnormal differentiation program of stratification, rather than apoptosis, leading to the observed hyperkeratosis. These data indicate that E4F1 inactivation strongly perturbates both the proliferation and differentiation of epidermal lineages in vivo leading to a strong alteration of skin homeostasis.
E4F1 inactivation induces epidermal stem cell defects.
We next investigated the mechanisms by which E4F1 inactivation in the IFE led to a massive but transient expansion of the basal/TAC compartment, followed by its exhaustion.
Several scenarios could explain this sequence of events. First this could reflect an increase in the intrinsic capacity of basal/TAC keratinocytes to proliferate. However, this is unlikely, since E4F1 depletion in freshly isolated populations of primary keratinocytes in culture did not recapitulate the massive over-proliferation observed in skin sections, as illustrated by To address this scenario, we first performed standard in vitro clonogenic assays on feeder layers with total primary keratinocytes isolated from in vivo recombined hyperplasic regions of E4F1 -/flox ; RERT adult mice, as well as from E4F1 -/flox ; K5-Cre p1 neonates or control littermates. After 10 to 15 days in culture, typical holoclones, corresponding to the long-term clonal outgrowth of epidermal cells with stem cell properties (25, 26) were detected in controls but not in E4F1 KO conditions in both models (Fig. 3A) . Importantly, similar results were recapitulated when E4F1 inactivation was induced ex vivo by adding 4OHT in the culture medium of E4F1 -/flox ; RERT cells ( Fig. 3A) , showing that these defects were stem cell autonomous. Similarly, clonogenic assays performed with primary human keratinocytes transduced ex vivo with E4F1 shRNA constructs showed that partial E4F1 depletion resulted in a 3 fold reduction in the number of holoclones ( Fig. 3B ).
We next investigated whether E4F1 inactivation also resulted in exhaustion of the stem cell pool in vivo by analysing expression of various ESC markers. FACscan analyses of dissociated epidermis revealed that E4F1 -/flox ; K5-Cre neonatal epidermis contained fewer ESC co-expressing the CD34 surface marker and high levels of α6-integrin (CD34 + /α6 high ) than control epidermis (8% +/-2 vs 1,5% +/-1, n=3) ( Fig. 3C ). Similarly, immunostainings performed on back skin sections or on whole mount of tail epidermis harvested from adult E4F1 -/flox ; RERT animals 4 to 6 weeks following E4F1 inactivation, showed loss of expression of the HF bulge markers CD34 and keratin-15 ( Fig. 3D and S6 ).
To confirm these HF ESC defects in vivo, we crossed E4F1 -/flox ; RERT animals with 26), we also observed that wound healing was strongly altered in E4F1 KO skin (figure S8). Altogether, these data indicate that E4F1 is essential for ESC maintenance in vivo and ex vivo, and strongly suggest that the hyperplasia and following loss of cellularity of E4F1 KO epidermis, are primarily due to cell autonomous perturbations of the ESC pool that aliments TAC compartments.
Down regulation of the Bmi1-Ink4a/Arf-p53 axis partly rescues ESC-clonogenic potential and skin lesions of E4F1 KO.
We next addressed the molecular pathway by which E4F1 could regulate ESC maintenance. E4F1 associates with the polycomb member Bmi1 and the tumor suppressors Arf, p53 and pRb (2) (3) (4) (5) 8) . Although there are evidences that these factors have independent functions, they define a well established functional cascade with Bmi1 triggering the repression of the Ink4a/Arf locus whose products, p19 Arf and p16 Ink4a , act as potent inhibitors of the p53-and pRb-dependent activities, respectively (29). Several reports suggest that the negative regulation of Ink4a/Arf expression may be a central event in stem cell renewal in several tissues (30-33) including epidermis (34). Strikingly, we observed that E4F1 KO primary keratinocytes exhibited enhanced Ink4a and Arf mRNA levels compared to control cells ( Fig. 4A ), suggesting that the deregulation of the Ink4a/Arf locus might be involved in To assess which Ink4a/Arf downstream targets might be involved, clonogenic assays were also performed upon shRNA-mediated (lentiviral vectors) depletion of either murine RB1 or p53 in E4F1 KO keratinocytes. p53 ( Fig. 5B and 5C ) but not pRb depletion restored
Discussion
In vivo functions of E4F1 remain poorly documented. Here, we created E4F1 conditional KO mice and reported that E4F1 inactivation in the epidermis led to neonatal lethality that resulted from skin homeostasis defects. We found that E4F1 depletion in E4F1 KO; K5-Cre neonates first led to a rapid thickening of the IFE associated with increased Seeking for the pathway by which E4F1 could regulate ESC maintenance, we found that the clonogenic potential of E4F1 KO ESC was restored upon targeting of the Bmi1-Ink4a/Arf-p53 axis but not by pRb depletion, highlighting the role of the Bmi-Arf-p53 axis rather than the Bmi-p16-pRb axis in E4F1 KO skin phenotypes. Consistently, E4F1
inactivation correlated with increased Ink4a/ARF expression and our in vivo data showed that the development of hyperplasia was delayed and reduced in animals with Ink4a/Arf and E4F1 compound gene deficiencies. It remains unclear how this protein network impinges on ESC homeostasis and ultimately raises the question about the physiological functions of this Bmi1-Ink4a/Arf-p53 axis in ESC. Although poorly documented, it has been suggested that it might play its usual "gate-keeper" function in these cells, notably in response to genotoxic or developmental stresses, as illustrated in mice with dysfunctional telomeres (35, 36) or in p63 KO mice (34, 37). As described in other tissues, it is also formally possible that the Bmi1-ARF-p53 protein network plays a role in the normal program of ESC self-renewal and maintenance. Hence, in absence of acute genotoxic stress, inactivation of p53 or Ink4a/Arf has been shown to impact on the self-renewal capacity of hematopoietic multipotent progenitors (38) and neural stem cells (39). Even more intriguing is the recent finding that p53 KO favours symmetric divisions and self-renewal capacity of mammary gland progenitor cells (40). The latter observation raises questions about similar roles of p53, and indirectly E4F1, in the epidermis where proper columnar stratification and tissue organization are driven, at least in part, by oriented, asymmetric cell divisions (41, 42).
Our data also highlight the complexity of E4F1 connections with the polycomb family member Bmi1. Indeed, others have shown that shRNA-mediated depletion of E4F1 can rescue premature senescence of Bmi1 KO hematopoietic stem cells and restore the viability of animals transplanted with those rescued cells, in a Ink4a/Arf-and p53-independent manner (5) . Our data indicate that the genetic links between E4F1 and Bmi1 in stem cell maintenance are complex and might differ from one tissue to the other since in epidermis, we clearly observed that Bmi1 ectopic overexpression partly rescued stem cell defects of E4F1 KO ESC.
Of note, we currently do not rule out that E4F1 might also exert yet unidentified additional cellular functions independent from Bmi1 and the Arf-p53 axis. Supporting this notion, we found that targeting the Bmi1-Arf-p53 axis did not fully restore ESC clonal outgrowth and normal skin phenotype. Animals with Ink4a/Arf and E4F1 compound gene deficiencies ended up to develop a moderate hyperplasia and hyperkeratosis at late time points. Likewise, in clonogenic assays, E4F1 KO rescued clones that developed upon depletion of p53 or Ink4a/Arf, or upon over-expression of Bmi1, all remained significantly smaller in size, compared to those growing from control cells. Therefore, in addition to its connection with the Bmi1-Arf-p53 cascade, one could hypothesize that E4F1 might also impinge on other hitherto described molecular circuitries that orchestrate epidermal stem cells maintenance, including TGFß-, Wnt/ß-catenin-, or Notch-initiated signalling cascades (12) (13) (14) .
Interestingly, a physical interaction of E4F1 with Smad4 has recently been shown in BMPmediated regulation of myogenic differentiation (10) . Further studies will be required to evaluate whether this interaction is also implicated in epidermal homeostasis.
In conclusion, the roadblock to developing an E4F1 conditional KO mouse has been overcome and provides the first evidence, that E4F1, through its connection with the Bmi1 and the Ink4a/Arf-p53 axis, is an important player of stem cells-dependent skin homeostasis.
This finding, together with previous reports showing that E4F1 is targeted by several oncoproteins and tumor suppressors, also raise an interesting question about E4F1 potential implication in the development/maintenance of cancer stem cells which presence is suspected in several cutaneous malignancies, including skin carcinoma and malignant melanoma.
Material and Methods:

Ethics Statement
All experiments involving mice were approved by Montpellier's ethic committee for animal warefare. 
Generation of E4F1
Histochemistry, immunolabelling of skin sections and whole mounts
Immunohistochemistry of skin sections was performed as described in SI with the following primary antibodies: anti -E4F1 (B-21 rabbit polyclonal) generated by our laboratory, -Ki67 (#SP6, Neomarkers), -keratin 6 (#SPM269, Abcam), -keratin10 (#PRB-159P, Covance), -involucrin (#Sc15230, Santa Cruz), -CD34 (RAM34, BD Pharmingen), and -keratin 15 (#LHK15, Vector Laboratories). Immunohistofluorescence stainings with anti-α6-integrin (#GoH3, BD Biosciences) and anti-keratin 14 (#AF64, Covance) were performed on 10μm cryosections fixed for 10 minutes in 100% acetone. BrdU-positive cells were detected using anti-BrdU antibody (BD Biosciences). Whole mounts of tail epidermis and detection of LRC were prepared as described previously (28) and pictures were generated using a Zeiss 510 confocal microscope and presented as Z-stack projections after deconvolution with Imaris software.
Culture of primary keratinocytes and clonogenic assays
Murine primary keratinocytes were isolated from newborn skin after overnight treatment with dispase (5 mg/mL, Roche) or from adult back skin after trypsin-EDTA overnight treatment, and grown in calcium-free EMEM medium (Biowhittaker, Lonza), containing 10% calciumfree FCS (Sigma) and 10 µg/ml murine EGF (Roche). Cre-mediated recombination of E4F1 flox alleles were achieved by adding 4OHT (1 µM, Sigma) in the culture medium. Human primary keratinocytes were isolated from skin biopsies obtained after medical surgery and cultured in Green medium containing 1,2 mM calcium as previously described (45) and according to Helsinki Declaration. Clonogenic assays were perfomed as described in SI.
Colonies were fixed with 4% PFA and stained with 1% Rhodamine B (Sigma). Quantitative analysis of the total number and size of clones was performed with ImageJ.
Retroviral and lentiviral particles productions and infections
Viral particles were produced as described in SI, with the following constructs: pMSCV-Bmi1 (29), pMKO vector encoding either control or anti human E4F1 shRNAs (sequences available upon request); pLKO1 encoding shRNAs directed against murine RB1 or p53 (Sigma mission shRNA clones, NM_011640.1-625s1c1), or control irrelevant sequence.
Western blotting
18
Total cell extracts were prepared in 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA, 0,5% NP40, supplemented with protease inhibitors (Complete, Roche). Immunoblots were probed with primary antibodies directed against E4F1 (8), p53 (1C12, Cell signalling), Bmi1 (#F6, Millipore), β-actin (Sigma)
FACScan analyses
Freshly isolated cell suspensions were incubated with FITC-conjugated anti-CD34 (RAM34, BD Biosciences) and PE-Cy5-conjugated anti-α6-integrin primary antibodies for 30 minutes at 4°C. For cell cycle analyses, formalin-fixed cells were incubated with anti-BrdU or antiphospho-serine 10 histone H3 (6G3 #9706, Cell Signalling) and PI (Sigma) as previously described (2) . Cells were analysed on a FACS Calibur (Becton Dickinson) and data were processed with Flowjo software (Treestar). 
Culture of primary keratinocytes and clonogenic assays
For cell cycle analyses, BrdU (10 mM, Sigma) was added in the culture medium for 24 hours. 
Retroviral and lentiviral particles productions and infections
